BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19390929)

  • 1. Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer.
    Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    Gastric Cancer; 2009; 12(1):31-6. PubMed ID: 19390929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer Lett; 2000 Apr; 151(1):81-6. PubMed ID: 10766426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Miyagi Y
    Gastric Cancer; 2006; 9(2):106-13. PubMed ID: 16767366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.
    Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Rino Y; Masuda M; Imada T
    Oncology; 2007; 72(3-4):205-8. PubMed ID: 18160809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer.
    Laitinen A; Hagström J; Mustonen H; Kokkola A; Tervahartiala T; Sorsa T; Böckelman C; Haglund C
    Tumour Biol; 2018 Sep; 40(9):1010428318799266. PubMed ID: 30192205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomartker for invasion and its impact on survival.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer; 2001 May; 91(9):1739-44. PubMed ID: 11335899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
    Li L; Zhang S; Lin H; Lin JY
    Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.
    Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Imada T; Noguchi Y
    Anticancer Res; 2004; 24(3b):2101-5. PubMed ID: 15274408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer.
    Wang YY; Li L; Zhao ZS; Wang HJ
    World J Surg Oncol; 2013 Apr; 11():81. PubMed ID: 23548070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma].
    Yoshikawa T; Suzuki K; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y; Tsuburaya A
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1461-4. PubMed ID: 9703854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma. A possible marker for serosal invasion and metastasis.
    Yoshikawa T; Saitoh M; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer; 1999 Nov; 86(10):1929-35. PubMed ID: 10570415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
    Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
    Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
    Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
    Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer.
    Kemik O; Kemik AS; Sümer A; Dulger AC; Adas M; Begenik H; Hasirci I; Yilmaz O; Purisa S; Kisli E; Tuzun S; Kotan C
    World J Gastroenterol; 2011 Apr; 17(16):2109-12. PubMed ID: 21547130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.
    Alpízar-Alpízar W; Laerum OD; Christensen IJ; Ovrebo K; Skarstein A; Høyer-Hansen G; Ploug M; Illemann M
    J Histochem Cytochem; 2016 Aug; 64(8):483-94. PubMed ID: 27370797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
    Lipton A; Ali SM; Leitzel K; Demers L; Evans DB; Hamer P; Brown-Shimer S; Pierce K; Carney W
    Cancer; 2007 May; 109(10):1933-9. PubMed ID: 17407159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S; Głażewska EK; Sobolewska M; Będkowska GE; Szmitkowski M
    Ann Lab Med; 2016 May; 36(3):223-9. PubMed ID: 26915610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.